| Dr Bob E Green, MD | |
|
19550 E 39th St S, Suite 227, Independence, MO 64057-2303 | |
| (816) 795-9716 | |
| (816) 795-6358 |
| Full Name | Dr Bob E Green |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 33 Years |
| Location | 19550 E 39th St S, Independence, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316946544 | NPI | - | NPPES |
| 100286810H | Medicaid | KS | |
| 1316946544 | Medicaid | MO | |
| 208692103 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MO112759 (Missouri) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 04-25504 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Ottawa | Ottawa, KS | Hospital |
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventhealth Ransom Memorial Inc | 4486996907 | 28 |
| Shawnee Mission Medical Center Inc | 9537119037 | 177 |
News Archive
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
A new study finds that Hispanics live in areas with more limited availability of colonoscopies and sigmoidoscopies for colorectal cancer screening. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that differences in areas' capacity for providing these procedures may explain why Hispanics are less likely to undergo colorectal cancer screening than non-Hispanic whites.
Landon S. King, M.D., the David Marine Professor of medicine and biological chemistry and director of the Division of Pulmonary and Critical Care Medicine has been named the next vice dean for research at Johns Hopkins Medicine, effective Sept. 1.
The impact of bipolar disorder during pregnancy has been hotly contended among the research community. Now, a new study from Lawson Health Research Institute and Western University is sorting out the debate and calling for more targeted, prospective research.
Takeda Pharmaceutical Company Limited and Zinfandel Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide licensing agreement regarding Zinfandel's TOMM40 assay as a biomarker for the risk of Alzheimer's disease in high-risk older adults with normal cognition. The companies will study pioglitazone in connection with the TOMM40 biomarker and Alzheimer's disease.
› Verified 2 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735690 PECOS PAC ID: 9537119037 Enrollment ID: O20050701000310 |
News Archive
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
A new study finds that Hispanics live in areas with more limited availability of colonoscopies and sigmoidoscopies for colorectal cancer screening. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that differences in areas' capacity for providing these procedures may explain why Hispanics are less likely to undergo colorectal cancer screening than non-Hispanic whites.
Landon S. King, M.D., the David Marine Professor of medicine and biological chemistry and director of the Division of Pulmonary and Critical Care Medicine has been named the next vice dean for research at Johns Hopkins Medicine, effective Sept. 1.
The impact of bipolar disorder during pregnancy has been hotly contended among the research community. Now, a new study from Lawson Health Research Institute and Western University is sorting out the debate and calling for more targeted, prospective research.
Takeda Pharmaceutical Company Limited and Zinfandel Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide licensing agreement regarding Zinfandel's TOMM40 assay as a biomarker for the risk of Alzheimer's disease in high-risk older adults with normal cognition. The companies will study pioglitazone in connection with the TOMM40 biomarker and Alzheimer's disease.
› Verified 2 days ago
| Entity Name | Adventhealth Ransom Memorial Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407319957 PECOS PAC ID: 4486996907 Enrollment ID: O20190510001418 |
News Archive
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
A new study finds that Hispanics live in areas with more limited availability of colonoscopies and sigmoidoscopies for colorectal cancer screening. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that differences in areas' capacity for providing these procedures may explain why Hispanics are less likely to undergo colorectal cancer screening than non-Hispanic whites.
Landon S. King, M.D., the David Marine Professor of medicine and biological chemistry and director of the Division of Pulmonary and Critical Care Medicine has been named the next vice dean for research at Johns Hopkins Medicine, effective Sept. 1.
The impact of bipolar disorder during pregnancy has been hotly contended among the research community. Now, a new study from Lawson Health Research Institute and Western University is sorting out the debate and calling for more targeted, prospective research.
Takeda Pharmaceutical Company Limited and Zinfandel Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide licensing agreement regarding Zinfandel's TOMM40 assay as a biomarker for the risk of Alzheimer's disease in high-risk older adults with normal cognition. The companies will study pioglitazone in connection with the TOMM40 biomarker and Alzheimer's disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bob E Green, MD 10308 State Line Rd, Suite A, Leawood, KS 66206-2658 Ph: (913) 381-7117 | Dr Bob E Green, MD 19550 E 39th St S, Suite 227, Independence, MO 64057-2303 Ph: (816) 795-9716 |
News Archive
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
A new study finds that Hispanics live in areas with more limited availability of colonoscopies and sigmoidoscopies for colorectal cancer screening. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that differences in areas' capacity for providing these procedures may explain why Hispanics are less likely to undergo colorectal cancer screening than non-Hispanic whites.
Landon S. King, M.D., the David Marine Professor of medicine and biological chemistry and director of the Division of Pulmonary and Critical Care Medicine has been named the next vice dean for research at Johns Hopkins Medicine, effective Sept. 1.
The impact of bipolar disorder during pregnancy has been hotly contended among the research community. Now, a new study from Lawson Health Research Institute and Western University is sorting out the debate and calling for more targeted, prospective research.
Takeda Pharmaceutical Company Limited and Zinfandel Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide licensing agreement regarding Zinfandel's TOMM40 assay as a biomarker for the risk of Alzheimer's disease in high-risk older adults with normal cognition. The companies will study pioglitazone in connection with the TOMM40 biomarker and Alzheimer's disease.
› Verified 2 days ago
Scott Koerber, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 19600 E 39th St S Ste 215, Independence, MO 64057 Phone: 816-461-6837 | |
Mrs. Fatima Ali, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 19550 E 39th St S Ste 310, Independence, MO 64057 Phone: 913-222-9779 Fax: 816-698-7378 | |
Dr. Mahesh Dutt Chandra, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4911 S Arrowhead Dr, Suite 200, Independence, MO 64055 Phone: 816-795-9595 Fax: 816-795-1188 | |
Stephen Dickson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 19550 E 39th St S Ste 215, Independence, MO 64057 Phone: 816-461-6837 | |
Brent W Beasley, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 16659 E 23rd St S, Independence, MO 64055 Phone: 816-688-6000 Fax: 816-631-1885 | |
Dr. Ritika Kaushal, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 913-222-9779 Fax: 816-312-4380 | |
Pamela Maben, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4911 S Arrowhead Dr, Suite 200, Independence, MO 64055 Phone: 816-795-9595 Fax: 816-795-1188 |